Medical Management of Menorrhagia in Pre- and Perimenopausal Women
Menstrual cycle intervals lengthen in perimenopausal women, while bleeding duration is unchanged, and 51% report changes in flow amount, with increased flow positively correlated with irregular menses.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (41)
- A comparative study of danazol, a regimen of decreasing doses of danazol, and norethindrone in the treatment of objectively proven unexplained menorrhagia via openalex
- A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia via openalex
- Assessment of medical treatments for menorrhagia via openalex
- Blood Production and Ovarian Secretion Rates of Estradiol-17β and Estrone in Women with Dysfunctional Uterine Bleeding via openalex
- Control of menorrhagia by the cyclo‐oxygenase inhibitors naproxen sodium and mefenamic acid via openalex
- Effects of mefenamic acid on menstrual hemostasis in essential menorrhagia via openalex
- Endometrial sex steroid receptor expression in women with menorrhagia via openalex
- Evaluation of surgical options in menorrhagia via openalex
- Levonorgestrel‐releasing intrauterine device in the treatment of menorrhagia via openalex
- Primary and myoma‐associated menorrhagia: role of prostaglandins and effects of ibuprofen via openalex
- PROSTAGLANDIN SYNTHESIS IN THE ENDOMETRIUM OF WOMEN WITH OVULAR DYSFUNCTIONAL UTERINE BLEEDING via openalex
- Randomized Trial of 2 Hormonal and 2 Prostaglandin‐inhibiting Agents in Women with a Complaint of Menorrhagia via openalex
- REDUCTION OF MENSTRUAL BLOOD LOSS BY DANAZOL IN UNEXPLAINED MENORRHAGIA: LACK OF EFFECT OF PLACEBO via openalex
- The effects of danazol mefanamic acid, norethistherone and a progesterone-impragnated coil on endometrial prostaglandin concentrations in women with monorrhagia via openalex
- The potential for the use of GnRH agonists for treatment of dysfunctional uterine bleeding via openalex
- Treatment of menorrhagia with intrauterine release of progesterone via openalex
- W2086126831 via openalex
- W2091692603 via openalex
- W2096468388 via openalex
- W2098847030 via openalex
- W2340070178 via openalex
- W2430911697 via openalex
- W2431968125 via openalex
- W4231570323 via openalex
- W63062164 via openalex
- W4248370513 via openalex
- W1678246774 via openalex
- W1783602832 via openalex
- W1976044138 via openalex
- W1981616577 via openalex
- W1985320906 via openalex
- W1988456452 via openalex
- W1988461890 via openalex
- W1992954195 via openalex
- W1993050841 via openalex
- W1997097468 via openalex
- W2012571604 via openalex
- W2014564190 via openalex
- W2020431417 via openalex
- W2037729117 via openalex
- W2081458881 via openalex
Cited by (1)
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00